This IFrame contains external resources. The provider may be collecting information about your interaction with this content by using cookies and may use this for targeting their offers. Please accept cookies in order to show the IFrame.
The race to find a cure for Covid-19 saw an estimated USD25bn spent on pharmaceutical R&D in 2020 alone, with half coming from the US’s "Operation Warp Speed".
After finishing 2020 on a high note with a vaccine light at the end of the tunnel, Europe now faces a moment of truth: a five-week delay on the vaccination front that, if left uncorrected, could cost close to EUR90bn in 2021.
The Asia-Pacific region has fared better than most other regions during the Covid-19 crisis: Economic activity is likely to have declined by less than -2% in 2020, compared to more than -4% at the global level and almost -8% in Latin America.